Medical Marijuana, Inc. Portfolio Company PhytoSPHERE Systems Announces Successful Production of Hemp Harvesting for High Value CBD Oil
SAN DIEGO, Sept. 7, 2012 /PRNewswire/ — Medical Marijuana, Inc. (OTC: MJNA), a leading hemp industry innovator, is pleased to announce that its portfolio company PhytoSPHERE Systems, which develops pharmaceutical grade medicinal hemp production facilities that produce high grade oil, is harvesting 1,000 acres of Hemp from its microclimate fields throughout Europe.
In the coming months, the crops will produce in excess of 2,000 kilograms of raw Hemp oil that will be used to fill new and existing contracts. The crops will provide high concentrate Hemp cannabidiol (CBD) oil for another MJNA portfolio company, Red Dice Holdings. Red Dice Holdings will then use the oil to fulfill orders for its Dixie X products– three new Hemp-based medical delivery systems that have the potential to deliver pain relief without the psychotropic effects of THC. To read more about the medical benefits and studies of Hemp-based CBD please click the following links:
- Medical Marijuana, Inc: http://tinyurl.com/8g7bqlw
- CanChew Biotechnologies: http://tinyurl.com/bug322p
- Project CBD: http://tinyurl.com/bukvhue
- Patients Out of Time: http://tinyurl.com/8ll632s
“We are pleased to be ahead of schedule with the harvesting of several of our Hemp crops. The harvest will enable us to produce a large-scale quantity of Hemp oil for our newly launched Dixie X product line and our soon to be launched patented CanChew medicinal gum, both of which rely on Hemp-based CBD instead of THC thus eliminating psychoactive effects. In many ways, we see our Hemp-based medical delivery systems as the future of our industry for the millions of patients who desire CBD wellness products,” said Michael Llamas, President of Medical Marijuana, Inc.
Please visit this link for photos of the most recent harvest: http://www.medicalmarijuanainc.com/index.php/pictures
About Medical Marijuana, Inc.
Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally friendly, economically sustainable businesses, while increasing shareholder value.
Medical Marijuana, Inc. does not grow, sell or distribute any substances that violate United States Law or the controlled substance act.
For more information, please visit the company’s website at:
About PhytoSPHERE Systems, LLC
PhytoSPHERE Systems, LLC is the world’s leading cannabinoid based Hemp biotechnology company that builds and develops growing, packaging and extraction technologies and deploys them in self-contained, highly efficient state of the art facilities as well as traditional hemp agricultural facilities, for the pharmaceutical and neutraceutical raw ingredients markets. PhytoSPHERE Systems has documented over 200 industrial hemp varieties and has identified specific ones with the highest levels of Cannabidiol for further development and production by PhytoSPHERE Systems.
PhytoSPHERE’s highly efficient growth, packaging and extraction technologies provide clients with a compact, safe, pollutant-free facility.
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the Food and Drug Administration (FDA). These products and statements are not intended to diagnose, treat, cure, or prevent any disease.
Investor Relations Contact:
Stuart T. Smith
SOURCE Medical Marijuana, Inc.